GSK PLC Sponsored ADR (GSK)
(Delayed Data from NYSE)
$40.59 USD
+0.84 (2.11%)
Updated Apr 22, 2024 04:00 PM ET
After-Market: $40.59 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth C Momentum A VGM
GSK (GSK) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$45.70 | $49.50 | $42.30 | 14.97% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for GSK comes to $45.70. The forecasts range from a low of $42.30 to a high of $49.50. The average price target represents an increase of 14.97% from the last closing price of $39.75.
Analyst Price Targets (4 )
Broker Rating
GSK currently has an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 10 brokerage firms. The current ABR compares to an ABR of 3.00 a month ago based on 10 recommendations.
Of the 10 recommendations deriving the current ABR, three are Strong Buy, representing 30% of all recommendations. A month ago, Strong Buy represented 30%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 2 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 3 | 3 | 3 | 4 |
Sell | 2 | 2 | 2 | 2 | 2 |
Strong Sell | 2 | 2 | 2 | 2 | 2 |
ABR | 3.00 | 3.00 | 3.00 | 3.22 | 3.44 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
3/4/2024 | Guggenheim Securities | Seamus Fernandez | Not Available | Strong Buy |
9/6/2023 | Not Identified | Not Identified | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.00 |
ABR (Last week) | 3.00 |
# of Recs in ABR | 10 |
Average Target Price | $45.70 |
LT Growth Rate | 7.10% |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 86 of 252 |
Current Quarter EPS Est: | 0.94 |